A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease
Condition: Alzheimer Disease · Cognitive Dysfunction · Dementia · Sponsor: Janssen Research & Development, LLC
About this study
The primary purpose of this study is to evaluate the effect of JNJ-63733657 versus placebo on clinical decline as measured by the Integrated Alzheimer's Disease Rating Scale (iADRS), a composite of cognition and function.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (122)
| University of Alabama Birmingham | Birmingham, Alabama, United States | — |
| Dignity Health | Phoenix, Arizona, United States | — |
| Irvine Clinical Research | Irvine, California, United States | — |
| University of California San Diego Medical Center | La Jolla, California, United States | — |
| University of California - Los Angeles | Los Angeles, California, United States | — |
| Stanford University Medical Center | Palo Alto, California, United States | — |
| Pacific Research Network Prn | San Diego, California, United States | — |
| Syrentis Clinical Research | Santa Ana, California, United States | — |
| Yale University School Of Medicine | New Haven, Connecticut, United States | — |
| Georgetown University Clinical Research Unit CRU | Washington D.C., District of Columbia, United States | — |
| JEM Research LLC | Atlantis, Florida, United States | — |
| Brain Matters Research | Delray Beach, Florida, United States | — |
+ 110 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04619420